Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions
Single dose of RN0191 achieved up to 95% individual maximum and 87% mean maximum PCSK9 reduction, and up to 74% individual maximum and 56% mean maximal LDL-C lowering... Read more.
LG Energy Solution Signs MoU with Bear Robotics to Become Exclusive Supplier of Cylindrical Batteries
LG Energy Solution’s cylindrical batteries to power Bear Robotics’ service and logistics robots starting from next year In addition to exclusive battery... Read more.
Green energy, space, agriculture: China, Brazil deepen cooperation on sustainable development
BEIJING, Nov. 17, 2024 /PRNewswire/ — Brazil officially assumed the one-year presidency of the G20 in December 2023, with the motto “Building a just... Read more.
Stormstrike Inc. Relocates Headquarters to Las Vegas, Fabien Bonte Joins as CEO
LAS VEGAS, Nov. 17, 2024 /PRNewswire/ — Stormstrike Inc., the pioneering digital media company known for its popular sports gaming platforms MUT.GG and FUT.GG,... Read more.
Gubagoo and Fullpath Unveil Curator, the First Unified Intelligence Engine for Automotive Retailers
Curator brings together every type of data across a dealership and normalizes, cleanses, and deduplicates it, creating a single unique view of every customer. HOUSTON... Read more.
Ascentage Pharma Announces a New Drug Application for Its Novel Bcl-2 Inhibitor Lisaftoclax Accepted and Recommended Priority Review Designation by CDE of China NMPA
ROCKVILLE, Md. and SUZHOU, China, Nov. 17, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing... Read more.
Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024
New preclinical results support the anti-fibrotic potential of engineered macrophages in multiple fibrosis models Engineered TIM4-expressing macrophages correct... Read more.
CGTN: How does Chancay Port light up Asia-Pacific cooperation?
BEIJING, Nov. 16, 2024 /PRNewswire/ — From the arrival of the first ship at Chancay Port to its official inauguration, the port has gained global attention... Read more.
CGTN: Starting a new era in Asia-Pacific development amid global uncertainty
BEIJING, Nov. 16, 2024 /PRNewswire/ — Over the decades, the Asia-Pacific region has been a vital driver of global economic growth. In October, the International... Read more.
AbelZeta Presents Preclinical Data from Study of C-CAR168 for the Treatment of Autoimmune Diseases at ACR Convergence 2024
Novel Anti-CD20/BCMA Bispecific Autologous CAR-T Therapy targeting LN and SLE ROCKVILLE, Md., Nov. 16, 2024 /PRNewswire/ — AbelZeta Pharma, Inc. (“AbelZeta”... Read more.